Pre-ligand assembly domain of the IL-17 receptor
    3.
    发明授权
    Pre-ligand assembly domain of the IL-17 receptor 失效
    IL-17受体的前配体组装结构域

    公开(公告)号:US08460647B2

    公开(公告)日:2013-06-11

    申请号:US12595585

    申请日:2008-04-20

    摘要: The invention provides isolated Pre-Ligand Assembly Domain (PLAD) polypeptides comprising an amino acid sequence of a domain (e.g., a Fibronectin Ill-like domain) of an IL-17 Receptor (IL-17R) family member, wherein the PLAD polypeptide inhibits multimerization of a receptor complex comprising an IL-17R family member. Also provided are isolated PLAD-binding polypeptides, e.g., antibodies and avimers, which specifically bind to a PLAD polypeptide described herein. Related chimeric proteins, conjugates, nucleic acids, vectors, and host cells are provided herein. Further provided are methods of treating an inflammatory or autoimmune disease, methods of inhibiting IL-17-mediated signal transduction, methods of inhibiting IL-17 ligand binding, methods of inhibiting multimerization of IL-17R complexes, and methods of inhibiting the production of at least one cytokine, chemokine, matrix metalloproteinase, or other molecule associated with IL-17 signal transduction are provided.

    摘要翻译: 本发明提供了包含IL-17受体(IL-17R)家族成员的结构域(例如,纤连蛋白III样结构域)的氨基酸序列的分离的前配体组装域(PLAD)多肽,其中PLAD多肽抑制 包含IL-17R家族成员的受体复合物的多聚化。 还提供了分离的PLAD结合多肽,例如特异性结合本文所述的PLAD多肽的抗体和avim。 本文提供了相关嵌合蛋白,缀合物,核酸,载体和宿主细胞。 还提供了治疗炎性或自身免疫性疾病的方法,抑制IL-17介导的信号转导的方法,抑制IL-17配体结合的方法,抑制IL-17R复合物多聚化的方法,以及抑制IL-17介导的信号转导的方法 提供了至少一种细胞因子,趋化因子,基质金属蛋白酶或与IL-17信号转导相关的其它分子。